The Investment Strategy Behind Harvard’s Record Endowment — and How It Fell Apart

After weeks of protests and a brutal crackdown that led to several hundred deaths, Bangladesh’s Prime Minister Sheikh Hasina was forced to step down and flee the country, putting an abrupt end to her more than 15 years in power. Stepping into the leadership vacuum is Nobel Prize-winning economist Muhammad Yunus, who we spoke to last month -- when he was facing charges that his supporters said were trumped up by Hasina.  Today on The Big Take Asia, host K. Oanh Ha speaks to Bloomberg’s Kai Schultz about what drove the student-led uprising and Hasina’s downfall, Yunus’s surprising turn to politics, and what’s at stake for one of Asia’s most promising economies. Read more:  Yunus Cleared in Graft Case After Becoming Bangladesh Leader Further listening:  Why This Nobel Prize Winner Faces Life Imprisonment in BangladeshSee omnystudio.com/listener for privacy information.

13 Aug 202416min

The sovereign wealth funds of the Persian Gulf used to be relatively easy places for US firms like Blackstone and Goldman Sachs to raise money. But recently, the power dynamics between Wall Street and Middle Eastern wealth fund managers have been shifting. On today’s Big Take podcast, Bloomberg’s Heather Perlberg breaks down for host David Gura why Middle Eastern sovereign wealth funds are asking for more in return for access to their trillions — and what that means not only for investors but also the future of the region. Read more: Middle East Trillions Force New Concessions From Wall StreetSee omnystudio.com/listener for privacy information.

12 Aug 202410min

Have you had the flu recently? Or RSV? Or just... some bug that you can’t quite shake? If so, you’re not alone. Bloomberg’s data team recently decided to investigate whether or not the perception that we’re all getting sick all the time is actually backed up by numbers. And what they found was truly surprising: in countries around the world, people are getting much sicker, much more often in the wake of the pandemic. We’re re-upping this episode, which originally aired on June 14, because – surprise – everyone’s still getting sick. Listen as host Sarah Holder and Bloomberg data reporter Jinshan Hong try to solve the global health mystery – including the potential culprits behind the surge in sickness and what we can do to avoid getting ill so often.See omnystudio.com/listener for privacy information.

9 Aug 202416min

On today’s Big Take podcast, economist Claudia Sahm explains the Sahm rule: how she came up with the idea, whether or not we’re in a recession, and why she wishes it was called something else.See omnystudio.com/listener for privacy information.

8 Aug 202415min

What happens when new weight-loss drugs like Ozempic transform a community? Bloomberg healthcare reporter Madison Muller went to Bowling Green, Kentucky to find out. That area has one of the highest concentrations of weight-loss drug prescriptions in the US. On today’s Big Take podcast, we explore what that means for people who live there, how these drugs are reshaping the local economy, and what it could look like in other places when Ozempic comes to town. Read more: What Happens When Ozempic Takes Over Your Town Listen more: Are Cheaper Ozempic Knockoffs Safe?See omnystudio.com/listener for privacy information.

7 Aug 202414min

Gautam Adani, the controversial Indian billionaire, gathered his two sons and two nephews for a family lunch one day and asked them a bombshell question: Did they want to carve up the Adani Group’s sprawling businesses between themselves or stick together? He gave them three months to decide. Today on The Big Take, host K. Oanh Ha talks to Bloomberg editor Anto Antony about the Adanis’ ambitious succession plan, in the wake of regulatory probes and a daring short-seller attack. We also hear from the Adanis themselves on their vision of an Adani Group without Gautam at the helm, how they’ll make decisions to manage an empire – which spans everything from airports to solar farms – and what's at stake for India’s $3.5 trillion economy. Read more: Adani Unveils $213 Billion Succession Plan as Scrutiny PersistsFurther listening: The Rise of Modi: Why India’s Leader Is So Popular – and Polarizing  See omnystudio.com/listener for privacy information.

6 Aug 202416min

On Wall Street, the S&P 500 had its worst day in nearly two years and the Dow Jones Industrial Average shed over 1,000 points. Shares on Japan’s Nikkei Index fell by over 12% — their worst showing since Black Monday in 1987. Cryptocurrencies dropped, bond yields rose and the VIX, known as the fear index, saw its biggest one-day spike in more than 30 years. Is the Fed to blame? AI over-exuberance? Warren Buffett? On today’s episode, Bloomberg columnist John Authers walks host David Gura through the global market meltdown: what triggered it, how long it could last, and when to panic. Read more:  $6.4 Trillion Stock Wipeout Has Traders Fearing ‘Great Unwind’ Is Just StartingFurther listening: Why the Market’s Big Tailwinds Are Coming to an EndSee omnystudio.com/listener for privacy information.

5 Aug 202416min

In April of 2023, a man carrying a small, black box walked into one of the nation’s most secure buildings, right next to the White House. In the box were ingredients that could be used to create a bioweapon. What the man revealed about how he got his hands on these ingredients was even scarier: an AI chatbot had given him the recipe. On today’s Big Take, host David Gura speaks to Bloomberg healthcare reporter Riley Griffin about why that stunt alarmed White House officials and woke them up to the potential dangers of AI-made bioweapons.  Read more: AI-Made Bioweapons Are Washington’s Latest Security Obsession Further listening:  We Can’t Opt Out of AI (But We Can Try) AI Wreaks Havoc on Global Power Systems See omnystudio.com/listener for privacy information.

2 Aug 202413min